Northwestern Mutual Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-442	Closed	-$23K	–	2544
2017 Q4	$23K	Sell	442 -95	-18%	-$5.2K	﹤0.01%	1468
2017 Q3	$31K	Buy	537 +41	+8%	+$2.4K	﹤0.01%	1309
2017 Q2	$30K	Sell	496 -108	-18%	-$6.15K	﹤0.01%	1259
2017 Q1	$32K	Buy	+604	New	+$29.8K	﹤0.01%	1172

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Northwestern Mutual Wealth Management's BIVV Position: Q1 2018 in Review

Northwestern Mutual Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 442 shares — an estimated $23K sold.

Northwestern Mutual Wealth Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $32K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Northwestern Mutual Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 442 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $23K.
Northwestern Mutual Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Bioverativ Inc. Common Stock position peaked at $32K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2018, filed 14 May 2018.